找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biologic and Systemic Agents in Dermatology; Paul S. Yamauchi Book 2018 Springer International Publishing AG 2018 systemic dermatology.bio

[复制链接]
楼主: Encomium
发表于 2025-3-30 08:20:50 | 显示全部楼层
发表于 2025-3-30 15:59:41 | 显示全部楼层
nd biologic agents, as well as their clinical efficacy and s. .Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agen
发表于 2025-3-30 20:18:05 | 显示全部楼层
Von der Nachkriegsnot zur Familienpolitik,logics. The chapter also discusses biosimilars and the complexity of their development and manufacturing along with highlighting the differences between two often-confused terms—biosimilarity and comparability.
发表于 2025-3-30 22:36:01 | 显示全部楼层
Manufacturing of Biologics,logics. The chapter also discusses biosimilars and the complexity of their development and manufacturing along with highlighting the differences between two often-confused terms—biosimilarity and comparability.
发表于 2025-3-31 01:47:10 | 显示全部楼层
发表于 2025-3-31 08:56:48 | 显示全部楼层
发表于 2025-3-31 10:33:38 | 显示全部楼层
Interpreting Clinical Trial Data,nical trials directly impacts clinical decision making, which ultimately guides patient management (Page, Int J Sports Phys Ther 9: 726, 2014). The purpose of this chapter is to provide an overview of fundamental aspects of clinical trials, such as study designs, analyses, and methods of handling mi
发表于 2025-3-31 14:48:29 | 显示全部楼层
发表于 2025-3-31 19:08:32 | 显示全部楼层
Quality of Life in the Dermatology Practice,ical functioning. The impact of these diseases on quality of life (QOL) can be significant, and the psychosocial impact of many dermatologic diseases is often more impactful than the physical appearance or symptoms alone. We now know that many chronic dermatologic conditions are more than skin deep,
发表于 2025-4-1 01:34:57 | 显示全部楼层
Medical Legal Issues with Biologic Agents in the Treatment of Psoriasis,n reported and the warning labels have expanded. A variety of issues are now linked to biologic associated tumor necrosis factor-alpha (TNF-α) blocker use. Litigation has occurred with the use of a variety of biologics. The published risks of these agents include the development of lupus and autoimm
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-22 21:28
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表